Medicare Enrolled
Dr. Jay Courtright, M.D.
Hematology & Oncology · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Courtright from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Courtright?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Courtright
Dr. Jay Courtright is a hematology & oncology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Courtright performed 4,151 Medicare services across 1,593 unique beneficiaries.
Between the years covered by Open Payments, Dr. Courtright received a total of $25,468 from 33 pharmaceutical and/or device companies across 90 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Courtright is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 40% volume in TX
$25,468 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,151
Medicare services
Top 40% in TX for hematology & oncology
1,593
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~218 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
635 | $10 | $64 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
547 | $8 | $36 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
482 | $8 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
365 | $94 | $368 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
324 | $0 | $1 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
259 | $64 | $250 |
| Injection, granisetron hydrochloride, 100 mcg | 170 | $0 | $24 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
165 | $6 | $31 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 146 | $20 | $128 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
108 | $13 | $60 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
105 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
105 | $6 | $34 |
| Iron level test | 94 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
94 | $9 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
78 | $11 | $96 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
55 | $58 | $211 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
50 | $61 | $247 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
45 | $38 | $135 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
41 | $17 | $61 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $120 | $565 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
39 | $105 | $707 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
37 | $23 | $157 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
37 | $23 | $161 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
26 | $94 | $357 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
22 | $12 | $108 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
20 | $4 | $23 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
20 | $1 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
18 | $51 | $313 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $81 | $372 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $102 | $470 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
17.0% medium
80.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,468
Total received (2018-2024)
Avg $3,638/year across 7 years
Top 18% in TX for hematology & oncology
33
Companies
90
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,001 (70.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,523 (21.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,943 (7.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,905
2023
$12,195
2022
$575
2021
$175
2020
$2,637
2019
$6,469
2018
$511
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$13,844
Blueprint Medicines Corporation
$3,839
Janssen Biotech, Inc.
$3,079
Seattle Genetics, Inc.
$1,592
Janssen Scientific Affairs, LLC
$1,226
CARTER BLOODCARE
$412
Seagen Inc.
$164
Genentech USA, Inc.
$161
AbbVie, Inc.
$148
Pharmacyclics LLC, An AbbVie Company
$124
ADC Therapeutics America, Inc.
$117
Myriad Genetic Laboratories, Inc.
$115
Celgene Corporation
$109
Carter BloodCare
$100
Karyopharm Therapeutics Inc.
$39
Merck Sharp & Dohme Corporation
$38
Daiichi Sankyo Inc.
$35
PFIZER INC.
$32
Gilead Sciences, Inc.
$30
Regeneron Healthcare Solutions, Inc.
$27
Ipsen Biopharmaceuticals, Inc
$24
Amgen Inc.
$24
Lilly USA, LLC
$22
Epizyme, Inc.,
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Exelixis Inc.
$20
Novartis Pharmaceuticals Corporation
$18
Heron Therapeutics, Inc.
$17
BeiGene USA, Inc.
$17
Genmab U.S., Inc.
$15
Medtronic USA, Inc.
$14
Verastem, Inc.
$14
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 81.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · BRUKINSA · CALQUENCE · CINVANTI · Cabometyx · Copiktra · DARZALEX · ERLEADA · Enhertu · Epkinly · IBRANCE · IMBRUVICA · IMFINZI · Imbruvica · KEYTRUDA · KISQALI · KYPHON Balloon Kyphoplasty · LIBTAYO · LUMAKRAS · LUMOXITI · PADCEV · Perjeta · PreciseTumor · RED BLOOD CELLS · SOMATULINE DEPOT · TAZVERIK · TUKYSA · Trodelvy · VENCLEXTA · VERZENIO · Venclexta · XPOVIO · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (71%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $614 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
134
Per 100K population
5.1
County median income
$74,149
Nearest hospital
MEDICAL CITY DALLAS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Courtright is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 18% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Courtright experienced with comprehensive metabolic blood panel?
Based on Medicare claims data, Dr. Courtright performed 635 comprehensive metabolic blood panel services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Courtright receive payments from pharmaceutical companies?
Yes. Dr. Courtright received a total of $25,468 from 33 companies across 90 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Courtright's costs compare to other hematology & oncology specialists in Dallas?
Dr. Courtright's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Courtright) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Dallas
Browse hematology & oncology specialists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Blueprint Medicines Corporation Payments to Doctors
See all physicians who received payments from Blueprint Medicines Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology